Contact Us
Drug Search Results
More Filters [+]

Vaxchora

Alternative Names: Vaxchora
Latest Update: 2024-01-22
Latest Update Note: Clinical Trial Update

Product Description

Vaxchora is the only FDA-approved, single-dose oral vaccine for the prevention of cholera caused by V cholerae serogroup O1 in adult travelers from the United States going to cholera-affected areas. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/28622736/)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Austria | Belgium | Croatia | Germany | Hungary | Indonesia | Ireland | Italy | Netherlands | New Zealand | Norway | Pakistan | Portugal | Russia | Spain | Taiwan | United Kingdom | United States | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Bavarian Nordic
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Vaxchora

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Cholera

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2018-003850-25

P3

Active, not recruiting

Cholera

2022-07-24

Recent News Events

Date

Type

Title

10/13/2023

News Article

 Cholera Vaccines Market Size, Share, Trends 2024-2032

10/11/2023

News Article

 Oral Cholera Vaccine Market Share, Projections and Future Opportunities Recorded For The Period Until 2023 to 2031

08/23/2023

News Article

 Bavarian Nordic Announces First Half 2023 Results

05/15/2023

News Article

 Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic

09/30/2022

PubMed

 Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022.

07/05/2022

PubMed

 Development of Pediatric Dosage Preparation for CVD 103-HgR Live Oral Cholera Vaccine.

01/01/2022

PubMed

 Update on CVD 103-HgR single-dose, live oral cholera vaccine.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions